Phase II study of dacarbazine given with modern prophylactic anti-emetics and growth factor support to patients with metastatic, resistant soft tissue, and bone sarcoma
- Brian A. Van Tine
- , Mia C. Weiss
- , Angela C. Hirbe
- , Peter J. Oppelt
- , Sarah Abaricia
- , Kathryn Trinkaus
- , Jingqin Luo
- , Shellie Berry
- , Tyler Ruff
- , Cheryl Callahan
- , Jacqui Toensikoetter
- , Jessica Ley
- , Marilyn J. Siegel
- , Farrokh Dehdashti
- , Barry A. Siegel
- , Douglas R. Adkins
- Section of Medical Oncology
- Bursky Center for Human Immunology and Immunotherapy
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Institute of Clinical and Translational Sciences (ICTS)
- Siteman Cancer Center
- Neurofibromatosis (NF) Center
- Division of Public Health Sciences
- Section of Pediatric Radiology
- Department of Radiology
- Division of Nuclear Medicine
- DBBS - Molecular Cell Biology
- DBBS - Molecular Genetics and Genomics
- DBBS - Cancer Biology
- Brain Tumor Center
Research output: Contribution to journal › Article › peer-review
2
Link opens in a new tab
Scopus
citations